{"id":"W3164705475","doi":"10.1016/s0140-6736(21)00588-2","title":"Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":543,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"AbbVie","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Placebo; Internal medicine; Randomized controlled trial; Clinical trial; Clinical endpoint; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002840491,0.002038511,0.006232272,0.0005996616,0.0004938142,0.001475527,0.001254318,0.003112075,0.005889776],"category_scores_gemma":[0.003323704,0.0009803113,0.005099939,0.0005357348,0.001351563,0.001946373,0.0005659436,0.004310912,0.0008014716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008985055,"about_ca_system_score_gemma":0.0007871396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001446827,"about_ca_topic_score_gemma":0.003285551,"domain_scores_codex":[0.9986105,0.0007298798,0.0001360668,0.0002358436,0.0001066218,0.0001810724],"domain_scores_gemma":[0.9984723,0.0005835405,0.000415227,0.0001080991,0.00009825686,0.000322545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.980641,0.001774949,0.0002963203,0.001752524,0.002240575,0.0000291073,0.0000616164,0.0001189217,0.0008708876,0.00005182405,0.0005288937,0.01163343],"study_design_scores_gemma":[0.9694492,0.02678608,0.001526375,0.0001072944,0.001347524,0.00002842002,0.00003468796,0.0001404246,0.0001548057,0.00009196907,0.0003175674,0.00001555665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448025,0.04421443,0.0009277064,0.001181463,0.001500954,0.003481304,0.001420032,0.0002175219,0.002253969],"genre_scores_gemma":[0.9790139,0.01163598,0.001348495,0.001381987,0.0006406922,0.002744355,0.0008076705,0.00002850821,0.002398369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006232272,"threshold_uncertainty_score":0.01970327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07452446434539767,"score_gpt":0.3370647134656402,"score_spread":0.2625402491202425,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}